Kestra Medical Technologies, Ltd.
Cash Flow Statement
| Line Item | Jul 2024 |
|---|---|
| Operating Activities | |
| Net Income | $-19.9M |
| Depreciation & Amortization | $2.4M |
| Depreciation | $2.4M |
| Amortization | — |
| Stock-Based Compensation | $377.0K |
| Net Cash from Operating Activities | $-17.5M |
| Investing Activities | |
| Capital Expenditures | $7.0M |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $-7.0M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $116.3M |
| Net Change in Cash | $91.7M |
| Free Cash Flow | $-24.5M |